Infection in systemic lupus erythematosus, similarities, and differences with lupus flare

키워드

참고문헌 (78)

1. Lisnevskaia L, "Systemic lupus erythematosus", Lancet, 384, pp.1878~1888 (2014)
2. 황지원, "Clinical characteristics of male and female Korean patients with systemic lupus erythematosus: a comparative study", The Korean Journal of Internal Medicine, 30(2), pp.242~249 (2015), 대한내과학회[DOI]
3. Hagberg N, "Systemic lupus erythematosus:a disease with a dysregulated type I interferon system", Scand J Immunol, 82, pp.199~207 (2015)
4. Ohl K, "Regulatory T cells in systemic lupus erythematosus", Eur J Immunol, 45, pp.344~355 (2015)
5. Esposito S, "Infections and systemic lupus erythematosus", Eur J Clin Microbiol Infect Dis, 33, pp.1467~1475 (2014)
6. Wucherpfennig KW., "Mechanisms for the induction of autoimmunity by infectious agents", J Clin Invest, 108, pp.1097~1104 (2001)
7. Jung JY, "Incomplete clearance of apoptotic cells in systemic lupus erythematosus: pathogenic role and potential biomarker", Int J Rheum Dis, 18, pp.294~303 (2015)
8. Munoz LE, "Apoptosis in the pathogenesis of systemic lupus erythematosus", Lupus, 17, pp.371~375 (2008)
9. Koutouzov S, "Type-I interferons and systemic lupus erythematosus", wAutoimmun Rev, 5, pp.554~562 (2006)
10. Draborg AH, "Epstein-Barr virus and systemic lupus erythematosus", Clin Dev Immunol, 2012, pp.370516~ (2012)
11. James JA, "An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus", J Clin Invest, 100, pp.3019~3026 (1997)
12. Perez-Mercado AE, "Cytomegalovirus as a trigger for systemic lupus erythematosus", J Clin Rheumatol, 16, pp.335~337 (2010)
13. Barzilai O, "Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report", Ann N Y Acad Sci, 1108, pp.567~577 (2007)
14. Francis L, "Infection in systemic lupus erythematosus:friend or foe?", Int J Clin Rheumtol, 5, pp.59~74 (2010)
15. Rasmussen NS, "Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients", Scand J Rheumatol, 44, pp.143~149 (2015)
16. Herrmann M, "Retroviruses and systemic lupus erythematosus", Immunol Rev, 152, pp.145~156 (1996)
17. Tugnet N, "Human endogenous retroviruses (HERVs) and autoimmune rheumatic disease: is there a link?", Open Rheumatol J, 7, pp.13~21 (2013)
18. Pullmann R Jr, "Haplotypes of the HRES-1 endogenous retrovirus are associated with development and disease manifestations of systemic lupus erythematosus", Arthritis Rheum, 58, pp.532~540 (2008)
19. Wu Z, "DNA methylation modulates HERV-E expression in CD4+ T cells from systemic lupus erythematosus patients", J Dermatol Sci, 77, pp.110~116 (2015)
20. Aslanidis S, "Parvovirus B19 infection and systemic lupus erythematosus: activation of an aberrant pathway?", Eur J Intern Med, 19, pp.314~318 (2008)
21. Gandhi MK, "Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments", Lancet Infect Dis, 4, pp.725~738 (2004)
22. Mohamed AE, "Real-time PCR of cytomegalovirus and Epstein-Barr virus in adult Egyptian patients with systemic lupus erythematosus", Int J Rheum Dis, 18, pp.452~458 (2015)
23. Chen J, "Correlation between systemic lupus erythematosus and cytomegalovirus infection detected by different methods", Clin Rheumatol, 34, pp.691~698 (2015)
24. Deng GM, "Cholera toxin B accelerates disease progression in lupus-prone mice by promoting lipid raft aggregation", J Immunol, 181, pp.4019~4026 (2008)
25. Versini M, "Unraveling the hygiene hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications", BMC Med, 13, pp.81~ (2015)
26. Vercelli D., "Mechanisms of the hygiene hypothesis: molecular and otherwise", Curr Opin Immunol, 18, pp.733~737 (2006)
27. Weinstock JV., "Autoimmunity: the worm returns", Nature, 491, pp.183~185 (2012)
28. Rook GA., "Hygiene hypothesis and autoimmune diseases", Clin Rev Allergy Immunol, 42, pp.5~15 (2012)
29. Oldstone MB, "Inhibition of antibodies to nuclear antigen and to DNA in New Zealand mice infected with lactate dehydrogenase virus", Science, 175, pp.784~786 (1972)
30. Clatworthy MR, "Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria", Proc Natl Acad Sci U S A, 104, pp.7169~7174 (2007)
31. Willcocks LC, "A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus", Proc Natl Acad Sci U S A, 107, pp.7881~7885 (2010)
32. Badr G, "Infection of female BWF1 lupus mice with malaria parasite attenuates B cell autoreactivity by modulating the CXCL12", CXCR4axis and its downstream signals PI3K, PLoS One, pp.2015, 10[DOI]
33. Abdel-Maksoud MA, "Infection with plasmodium chabaudi diminishes plasma immune complexes and ameliorates the histopathological alterations in different organs of female BWF1 lupus mice", Eur Rev Med Pharmacol Sci, 20, pp.733~744 (2016)
34. Chen M, "Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice", Int Immunol, 16, pp.937~946 (2004)
35. Rodgers DT, "The parasitic worm product ES-62 targets myeloid differentiation factor 88-dependent effector mechanisms to suppress antinuclear antibody production and proteinuria in MRL", lpr mice, 2015, pp.67, 1023~1035
36. Sawalha AH, "Association between systemic lupus erythematosus and Helicobacter pylori seronegativity", J Rheumatol, 31, pp.1546~1550 (2004)
37. Zhao J, "Low prevalence of hepatitis B virus infection in patients with systemic lupus erythematosus in southern China", Rheumatol Int, 30, pp.1565~1570 (2010)
38. Ram M, "The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders", Autoimmun Rev, 7, pp.621~625 (2008)
39. Petri M., "Infection in systemic lupus erythematosus", Rheum Dis Clin North Am, 24, pp.423~456 (1998)
40. Wang Z, "Long-term survival and death causes of systemic lupus erythematosus in China: a systemic review of observational studies", Medicine (Baltimore), 94, pp.e794~ (2015)
41. Goldblatt F, "Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality", Lupus, 18, pp.682~689 (2009)
42. Cuchacovich R, "Pathophysiology and clinical spectrum of infections in systemic lupus erythematosus", Rheum Dis Clin North Am, 35, pp.75~93 (2009)
43. Gladman DD, "The nature and outcome of infection in systemic lupus erythematosus", Lupus, 11, pp.234~239 (2002)
44. Borba EF, "Incidence, risk factors, and outcome of Herpes zoster in systemic lupus erythematosus", J Clin Rheumatol, 16, pp.119~122 (2010)
45. Hu SC, "Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): a nationwide case-control study", J Am Acad Dermatol, 75, pp.49~58 (2016)
46. Murray SG, "National lupus hospitalization trends reveal rising rates of herpes zoster and declines in pneumocystis pneumonia", PLoS One, 11, pp.e0144918~ (2016)
47. Ferreira JC, "Herpes zoster infection in childhood-onset systemic lupus erythematosus patients: a large multicenter study", Lupus, 25, pp.754~759 (2016)
48. Rondaan C, "Altered cellular and humoral immunity to varicella-zoster virus in patients with autoimmune diseases", Arthritis Rheumatol, 66, pp.3122~3128 (2014)
49. Ramos-Casals M, "Acute viral infections in patients with systemic lupus erythematosus:description of 23 cases and review of the literature", Medicine (Baltimore), 87, pp.311~318 (2008)
50. Tam LS, "Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection", Arthritis Rheum, 50, pp.3619~3625 (2004)
51. 이유현, "Prevalence of Human Papilloma Virus Infections and Cervical Cytological Abnormalities among Korean Women with Systemic Lupus Erythematosus", Journal of Korean Medical Science, 25(10), pp.1431~1437 (2010), 대한의학회
52. Nath R, "High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients", Arthritis Rheum, 57, pp.619~625 (2007)
53. Duffy KN, "Infection and disease activity in systemic lupus erythematosus: a review of hospitalized patients", J Rheumatol, 18, pp.1180~1184 (1991)
54. Bosch X, "Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients", Lupus, 15, pp.584~589 (2006)
55. Jeong SJ, "Incidence and risk factors of infection in a single cohort of 110 adults with systemic lupus erythematosus.", Scand J Infect Dis, 41, pp.268~274 (2009)
56. Suh CH, "Risk factors for infection and role of C-reactive protein in Korean patients with systemic lupus erythematosus", Clin Exp Rheumatol, 19, pp.191~194 (2001)
57. Houssiau FA, "Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide", Arthritis Rheum, 46, pp.2121~2131 (2002)
58. Cutolo M, "Use of glucocorticoids and risk of infections", Autoimmun Rev, 8, pp.153~155 (2008)
59. Feng PH, "Tuberculosis in patients with systemic lupus erythematosus", Ann Rheum Dis, 41, pp.11~14 (1982)
60. Kang I, "Infectious complications in SLE after immunosuppressive therapies", Curr Opin Rheumatol, 15, pp.528~534 (2003)
61. Chang YS, "Tuberculosis infection in primary Sjogren’s syndrome: a nationwide population-based study", Clin Rheumatol, 33, pp.377~383 (2014)
62. Prabu V, "Systemic lupus erythematosus and tuberculosis: a review of complex interactions of complicated diseases", J Postgrad Med, 56, pp.244~250 (2010)
63. Yun JE, "The incidence and clinical characteristics of Mycobacterium tuberculosis infection among systemic lupus erythematosus and rheumatoid arthritis patients in Korea", Clin Exp Rheumatol, 20, pp.127~132 (2002)
64. Cho H, "Concordance between the tuberculin skin test and interferon gamma release assay (IGRA) for diagnosing latent tuberculosis infection in patients with systemic lupus erythematosus and patient characteristics associated with an indeterminate IGRA", Lupus, 25, pp.1341~1348 (2016)
65. Suh CH, "Unresponsiveness of C-reactive protein in the non-infectious inflammation of systemic lupus erythematosus is associated with interleukin 6", Clin Immunol, 119, pp.291~296 (2006)
66. Kim HA, "C-reactive protein is a more sensitive and specific marker for diagnosing bacterial infections in systemic lupus erythematosus compared to S100A8", A9 and procalcitonin, 2012, pp.39, 728~734
67. Kim HA, "The antichromatin antibodies can be useful as a diagnostic tool and disease activity marker of systemic lupus erythematosus in Koreans", Clin Immunol, 128, pp.277~283 (2008)
68. Beca S, "Development and validation of a risk calculator to differentiate flares from infections in systemic lupus erythematosus patients with fever", Autoimmun Rev, 14, pp.586~593 (2015)
69. Lacki JK, "Cytokine concentration in serum of lupus erythematosus patients: the effect on acute phase response", J Med, 28, pp.99~107 (1997)
70. Sciascia S, "Systemic lupus erythematosus and infections: clinical importance of conventional and upcoming biomarkers", Autoimmun Rev, 12, pp.157~163 (2012)
71. Pasoto SG, "Update on infections and vaccinations in systemic lupus erythematosus and Sjogren’s syndrome", Curr Opin Rheumatol, 26, pp.528~537 (2014)
72. van Assen S, "EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases", Ann Rheum Dis, 70, pp.414~422 (2011)
73. Aron-Maor A, "Vaccination and systemic lupus erythematosus: the bidirectional dilemmas", Lupus, 10, pp.237~240 (2001)
74. Wiesik-Szewczyk E, "Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety", Clin Rheumatol, 29, pp.605~613 (2010)
75. Elkayam O, "Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus", Clin Infect Dis, 34, pp.147~153 (2002)
76. Grimaldi-Bensouda L, "The risk of systemic lupus erythematosus associated with vaccines: an international case-control study", Arthritis Rheumatol, 66, pp.1559~1567 (2014)
77. Dell’ Era L, "Vaccination of children and adolescents with rheumatic diseases", Rheumatology (Oxford), 50, pp.1358~1365 (2011)
78. Elkayam O, "Pneumococcal vaccination of patients with systemic lupus erythematosus:effects on generation of autoantibodies", Autoimmunity, 38, pp.493~496 (2005)

관련 논문AI추천